Literature DB >> 8947479

Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24.

C Poinot-Chazel1, M Portier, M Bouaboula, N Vita, F Pecceu, D Gully, J G Monroe, J P Maffrand, G Le Fur, P Casellas.   

Abstract

Neurotensin (NT) is a neuropeptide that is important in a variety of biological processes such as signal transduction and cell growth. NT effects are mediated by a single class of cell-surface receptors, known as neurotensin receptors (NTRs), which exhibit structural features of the G-protein-coupled receptors superfamily. We investigated NTR signalling properties with Chinese hamster ovary (CHO) cells stably transformed with human NTR (hNTR). First, we showed that NTR stimulation by NT induced the activation of the mitogen-activated protein kinases (MAPKs) in time- and dose-dependent manners. Both p42 and p44 MAPK isoforms were retarded in gel-shift assays, which was consistent with their activation by phosphorylation. In addition we showed that NT caused a prolonged activation of MAPK as measured by in-gel kinase assay. Secondly, we demonstrated that NT induced the expression of the growth-related gene Krox-24 at the protein level, as assessed by Western-blot analysis, and at the transcriptional level, as demonstrated in CHO cells transfected with hNTR and a reporter gene for Krox-24. Activation of MAPK and induction of Krox-24 were both prevented by the NTR antagonist SR 48692, confirming the specific action on NTR. Furthermore we observed coupling of NTR to a mitogenic pathway and Krox-24 induction in the human adenocarcinoma cell line HT29, which naturally expresses NTRs. Considering coupling pathways between NTR stimulation and MAPK activation, we observed a partial inhibition by pertussis toxin (PTX) and a complete blockade by the protein kinase C (PKC) inhibitor GF 109203X. Taken together, these results suggest that (1) stimulation of NTR activates the MAPK pathway by mechanisms involving dual coupling to both PTX-sensitive and PTX-insensitive G-proteins as well as PKC activation, and (2) these effects are associated with the induction of Krox-24, which might be a target of MAPK effector.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947479      PMCID: PMC1217909          DOI: 10.1042/bj3200145

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  Structure and functional expression of the cloned rat neurotensin receptor.

Authors:  K Tanaka; M Masu; S Nakanishi
Journal:  Neuron       Date:  1990-06       Impact factor: 17.173

2.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

3.  Transformation of rat cells by DNA of human adenovirus 5.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

Review 4.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

5.  Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells.

Authors:  Y Gotoh; E Nishida; T Yamashita; M Hoshi; M Kawakami; H Sakai
Journal:  Eur J Biochem       Date:  1990-11-13

6.  Neurotensin regulates growth of human pancreatic cancer.

Authors:  J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

7.  Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor.

Authors:  N Vita; P Laurent; S Lefort; P Chalon; X Dumont; M Kaghad; D Gully; G Le Fur; P Ferrara; D Caput
Journal:  FEBS Lett       Date:  1993-02-08       Impact factor: 4.124

8.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Authors:  D Toullec; P Pianetti; H Coste; P Bellevergue; T Grand-Perret; M Ajakane; V Baudet; P Boissin; E Boursier; F Loriolle
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity.

Authors:  G Urlaub; L A Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Defective regulation of mitogen-activated protein kinase activity in a 3T3 cell variant mitogenically nonresponsive to tetradecanoyl phorbol acetate.

Authors:  G L'Allemain; T W Sturgill; M J Weber
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

View more
  12 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

2.  Ligand-mediated dephosphorylation signaling for MAP kinase.

Authors:  Nataliia V Shults; Faisal S Almansour; Vladyslava Rybka; Dante I Suzuki; Yuichiro J Suzuki
Journal:  Cell Signal       Date:  2018-09-10       Impact factor: 4.315

3.  Neurotensinergic augmentation of glutamate release at the perforant path-granule cell synapse in rat dentate gyrus: Roles of L-Type Ca²⁺ channels, calmodulin and myosin light-chain kinase.

Authors:  Haopeng Zhang; Hailong Dong; Saobo Lei
Journal:  Neuropharmacology       Date:  2015-04-02       Impact factor: 5.250

4.  Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells.

Authors:  Qingding Wang; Yuning Zhou; B Mark Evers
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

5.  Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells.

Authors:  Dezheng Zhao; Kyriaki Bakirtzi; Yanai Zhan; Huiyan Zeng; Hon Wai Koon; Charalabos Pothoulakis
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

6.  Exploratory Analysis of Plasma Neurotensin as a Novel Biomarker for Early Detection of Colorectal Polyp and Cancer.

Authors:  Shengyang Qiu; Stella Nikolaou; Francesca Fiorentino; Shahnawaz Rasheed; Ara Darzi; David Cunningham; Paris Tekkis; Christos Kontovounisios
Journal:  Horm Cancer       Date:  2019-05-15       Impact factor: 3.869

7.  Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells.

Authors:  Dezheng Zhao; Yanai Zhan; Huiyan Zeng; Hon Wai Koon; Mary P Moyer; Charalabos Pothoulakis
Journal:  Int J Cancer       Date:  2007-04-15       Impact factor: 7.396

8.  Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.

Authors:  Kristin M Müller; Ingun H Tveteraas; Monica Aasrum; John Ødegård; Mona Dawood; Olav Dajani; Thoralf Christoffersen; Dagny L Sandnes
Journal:  BMC Cancer       Date:  2011-10-02       Impact factor: 4.430

9.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555

10.  Diverse roles of neurotensin agonists in the central nervous system.

Authors:  Mona Boules; Zhimin Li; Kristin Smith; Paul Fredrickson; Elliott Richelson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-22       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.